Citations (66)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Maximiliano Vásquez, Eric Krauland, Laura Walker, Dane Wittrup & Tillman Gerngross. (2019) Connecting the sequence dots: shedding light on the genesis of antibodies reported to be designed in silico. mAbs 11:5, pages 803-808.
Read now
Read now
André Frenzel, Thomas Schirrmann & Michael Hust. (2016) Phage display-derived human antibodies in clinical development and therapy. mAbs 8:7, pages 1177-1194.
Read now
Read now
Michael L Salgaller. (2002) The development of immunotherapies for non-small cell lung cancer. Expert Opinion on Biological Therapy 2:3, pages 265-278.
Read now
Read now
. (1998) Transgenic non-human animals capable of producing heterologous antibodies. Expert Opinion on Therapeutic Patents 8:9, pages 1185-1189.
Read now
Read now
Articles from other publishers (62)
Kristian Daniel Ralph Roth, Esther Veronika Wenzel, Maximilian Ruschig, Stephan Steinke, Nora Langreder, Philip Alexander Heine, Kai-Thomas Schneider, Rico Ballmann, Viola Fühner, Philipp Kuhn, Thomas Schirrmann, André Frenzel, Stefan Dübel, Maren Schubert, Gustavo Marçal Schmidt Garcia Moreira, Federico Bertoglio, Giulio Russo & Michael Hust. (2021) Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
A. Prieto Martín, J. Barbarroja Escudero, S. Haro Girón & A. Pérez Gómez. (2021) Avances y perspectivas actuales en recursos y estrategias terapéuticas: fármacos biológicos. Medicine - Programa de Formación Médica Continuada Acreditado 13:33, pages 1882-1892.
Crossref
Crossref
Paweł Kręcisz, Kamila Czarnecka, Leszek Królicki, Elżbieta Mikiciuk-Olasik & Paweł Szymański. (2020) Radiolabeled Peptides and Antibodies in Medicine. Bioconjugate Chemistry 32:1, pages 25-42.
Crossref
Crossref
Sagun Parakh, Dylan King, Hui K. Gan & Andrew M. Scott. 2020. Current Immunotherapeutic Strategies in Cancer. Current Immunotherapeutic Strategies in Cancer
1
70
.
Sundo Jung. (2019) Efficient Generation of Human IgG1 Light Kappa Constant Region Knock-in Mouse by CRISPR/Cas9 System. Biomedical Science Letters 25:4, pages 372-380.
Crossref
Crossref
Erik Doevendans & Huub Schellekens. (2019) Immunogenicity of Innovative and Biosimilar Monoclonal Antibodies. Antibodies 8:1, pages 21.
Crossref
Crossref
Yiran Zhang, Chun Fan, Lijuan Zhang & Xuexiao Ma. 2019. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part B. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part B
471
485
.
Meng Zhang, Huaiqian Dou, Dandan Yang, Ming Shan, Xiulian Li, Cui Hao, Yiran Zhang, Pengjiao Zeng, Yanli He, Yong Liu, Jing Fu, Wei Wang, Minghui Hu, Hui Li, Qingwu Tian, Shuhe Lei & Lijuan Zhang. 2019. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A
141
163
.
Urai Chaisri & Wanpen Chaicumpa. (2018) Evolution of Therapeutic Antibodies, Influenza Virus Biology, Influenza, and Influenza Immunotherapy. BioMed Research International 2018, pages 1-23.
Crossref
Crossref
David J. Araten, Robert J. Mandle, David E. Isenman & Michael C. Carroll. 2018. Hematology. Hematology
261
284.e6
.
Michael Pohlscheidt, Robert Kiss & Uwe Gottschalk. 2018. New Bioprocessing Strategies: Development and Manufacturing of Recombinant Antibodies and Proteins. New Bioprocessing Strategies: Development and Manufacturing of Recombinant Antibodies and Proteins
1
8
.
Brooke I. Polk & Lanny J. Rosenwasser. (2017) Biological Therapies of Immunologic Diseases. Immunology and Allergy Clinics of North America 37:2, pages 247-259.
Crossref
Crossref
Marieke K. Zhao. 2017. Reference Module in Life Sciences. Reference Module in Life Sciences.
Philipp Kuhn, Viola Fühner, Tobias Unkauf, Gustavo Marcal Schmidt Garcia Moreira, André Frenzel, Sebastian Miethe & Michael Hust. (2016) Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display. PROTEOMICS – Clinical Applications 10:9-10, pages 922-948.
Crossref
Crossref
Ali Nazari Shirvan & Robert Aitken. (2016) Isolation of recombinant antibodies directed against surface proteins of Clostridium difficile. Brazilian Journal of Microbiology 47:2, pages 394-402.
Crossref
Crossref
Tobias Unkauf, Sebastian Miethe, Viola Fühner, Thomas Schirrmann, André Frenzel & Michael Hust. 2016. Protein Targeting Compounds. Protein Targeting Compounds
55
76
.
Florian Tomszak, Susanne Weber, Jonas Zantow, Thomas Schirrmann, Michael Hust & André Frenzel. 2016. Protein Targeting Compounds. Protein Targeting Compounds
23
54
.
Cornelia Volz & Diana Pauly. (2015) Antibody therapies and their challenges in the treatment of age-related macular degeneration. European Journal of Pharmaceutics and Biopharmaceutics 95, pages 158-172.
Crossref
Crossref
Tobias Unkauf, Sebastian Miethe, Viola Fühner, Thomas Schirrmann, André Frenzel & Michael Hust. 2015. Protein Targeting Compounds. Protein Targeting Compounds
55
76
.
Michael Hust, André Frenzel, Florian Tomszak, Jonas Kügler & Stefan Dübel. 2014. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies
43
76
.
Christopher Chang. (2014) Unmet needs in the treatment of autoimmunity: From aspirin to stem cells. Autoimmunity Reviews 13:4-5, pages 331-346.
Crossref
Crossref
Michael Hust, André Frenzel, Thomas Schirrmann & Stefan Dübel. 2014. Gene Function Analysis. Gene Function Analysis
305
320
.
Sotirios Kotsovilis & Evangelos Andreakos. 2014. Human Monoclonal Antibodies. Human Monoclonal Antibodies
37
59
.
André Frenzel, Jonas Kügler, Sonja Wilke, Thomas Schirrmann & Michael Hust. 2014. Human Monoclonal Antibodies. Human Monoclonal Antibodies
215
243
.
A.L. Catapano & N. Papadopoulos. (2013) The safety of therapeutic monoclonal antibodies: Implications for cardiovascular disease and targeting the PCSK9 pathway. Atherosclerosis 228:1, pages 18-28.
Crossref
Crossref
Waliza AnsarShyamasree Ghosh. (2013) Monoclonal Antibodies: A Tool in Clinical Research. Indian Journal of Clinical Medicine 4, pages IJCM.S11968.
Crossref
Crossref
Eryl Liddell. 2013. The Immunoassay Handbook. The Immunoassay Handbook
245
265
.
Yu Zhou, Lequn Zhao & James D. Marks. (2012) Selection and characterization of cell binding and internalizing phage antibodies. Archives of Biochemistry and Biophysics 526:2, pages 107-113.
Crossref
Crossref
Hélène Le Buanec, Armand Bensussan, Martine Bagot, Robert C. Gallo & Daniel Zagury. 2012. Advances in Immunology Volume 115. Advances in Immunology Volume 115
187
227
.
C. Ronald Geyer, John McCafferty, Stefan Dübel, Andrew R. M. Bradbury & Sachdev S. Sidhu. 2012. Antibody Methods and Protocols. Antibody Methods and Protocols
11
32
.
Thomas Schirrmann, Torsten Meyer, Mark Schütte, André Frenzel & Michael Hust. (2011) Phage Display for the Generation of Antibodies for Proteome Research, Diagnostics and Therapy. Molecules 16:1, pages 412-426.
Crossref
Crossref
Michael Hust & Stefan Dübel. 2010. Antibody Engineering. Antibody Engineering
65
84
.
Thomas Schirrmann & Michael Hust. 2010. Immunotherapy of Cancer. Immunotherapy of Cancer
177
209
.
Michael Hust, Holger Thie, Thomas Schirrmann & Stefan Dbel. 2009. Therapeutic Monoclonal Antibodies. Therapeutic Monoclonal Antibodies
189
211
.
Nils Lonberg. 2009. Therapeutic Monoclonal Antibodies. Therapeutic Monoclonal Antibodies
115
150
.
Yann Echelard. (2009) Year of the ox. Nature Biotechnology 27:2, pages 146-147.
Crossref
Crossref
Peter J. Bugelski. 2008. Immunotoxicology Strategies for Pharmaceutical Safety Assessment. Immunotoxicology Strategies for Pharmaceutical Safety Assessment
319
343
.
N. Lonberg. 2008. Therapeutic Antibodies. Therapeutic Antibodies
69
97
.
Zhenping ZHU. (2007) Targeted cancer therapies based on antibodies directed against epidermal growth factor receptor: status and perspectives. Acta Pharmacologica Sinica 28:9, pages 1476-1493.
Crossref
Crossref
Christopher D. Reed, Heidi Rast, Wei-gang Hu, David Mah, Les Nagata & Saad A. Masri. (2007) Expression of furin-linked Fab fragments against anthrax toxin in a single mammalian expression vector. Protein Expression and Purification 54:2, pages 261-266.
Crossref
Crossref
Saad A. Masri, Heidi Rast, Wei-Gang Hu, Les P. Nagata, Damon Chau, Scott Jager & David Mah. (2007) Cloning and expression in E. coli of a functional Fab fragment obtained from single human lymphocyte against anthrax toxin. Molecular Immunology 44:8, pages 2101-2106.
Crossref
Crossref
Michael Hust, Lars Toleikis & Stefan Dübel. 2007. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies
45
68
.
ZHENPING ZHU. 2007. Target Validation in Drug Discovery. Target Validation in Drug Discovery
43
67
.
Michael Hust, Stefan Dübel & Thomas Schirrmann. 2007. Gene Function Analysis. Gene Function Analysis
243
255
.
Li Yan & Zhenping Zhu. (2006) Development of antibody-based therapeutics for oncology indications. Drug Development Research 67:9, pages 699-728.
Crossref
Crossref
Sumapa Chaiamnuay & S. Louis BridgesJr.Jr.. (2005) The role of B cells and autoantibodies in rheumatoid arthritis. Pathophysiology 12:3, pages 203-216.
Crossref
Crossref
Saul Tzipori, Abhineet Sheoran, Donna Akiyoshi, Arthur Donohue-Rolfe & Howard Trachtman. (2004) Antibody Therapy in the Management of Shiga Toxin-Induced Hemolytic Uremic Syndrome. Clinical Microbiology Reviews 17:4, pages 926-941.
Crossref
Crossref
MARIANNE BRÜGGEMANN. 2004. Molecular Biology of B Cells. Molecular Biology of B Cells
547
561
.
Zhenping Zhu & Daniel J. Hicklin. 2004. Cellular Drug Delivery. Cellular Drug Delivery
311
344
.
Yann Echelard & Harry Meade. (2002) Toward a new cash cow. Nature Biotechnology 20:9, pages 881-882.
Crossref
Crossref
Mitchell E. Reff & Cheryl Heard. (2001) A review of modifications to recombinant antibodies: attempt to increase efficacy in oncology applications. Critical Reviews in Oncology/Hematology 40:1, pages 25-35.
Crossref
Crossref
Marc A van Dijk & Jan G.J van de Winkel. (2001) Human antibodies as next generation therapeutics. Current Opinion in Chemical Biology 5:4, pages 368-374.
Crossref
Crossref
Serge Muyldermans. (2001) Single domain camel antibodies: current status. Reviews in Molecular Biotechnology 74:4, pages 277-302.
Crossref
Crossref
Robert I. Roth. (2001) Magic Bullets Finally Find Their Mark. Journal of the American Pharmaceutical Association (1996) 41:3, pages 383-391.
Crossref
Crossref
Jean-Henri Bézian, Daniel Moynet, Sylvie Comeau & Jean-Luc Chagnaud. (2000) L'ingénierie des anticorps et ses applications. Revue Française des Laboratoires 2000:327, pages 105-109.
Crossref
Crossref
M Little, S.M Kipriyanov, F Le Gall & G Moldenhauer. (2000) Of mice and men: hybridoma and recombinant antibodies. Immunology Today 21:8, pages 364-370.
Crossref
Crossref
Enrico Mastrobattista, Gerben A Koning & Gert Storm. (1999) Immunoliposomes for the targeted delivery of antitumor drugs. Advanced Drug Delivery Reviews 40:1-2, pages 103-127.
Crossref
Crossref
Gerd Pluschke, Andrea Joss, Jutta Marfurt, Claudia Daubenberger, Oscar Kashala, Markus Zwickl, Aribert Stief, Gilles Sansig, Beatrice Schläpfer, Susanne Linkert, Herman van der Putten, Norman Hardman & Markus Schröder. (1998) Generation of chimeric monoclonal antibodies from mice that carry human immunoglobulin Cγ1 heavy or Cκ light chain gene segments. Journal of Immunological Methods 215:1-2, pages 27-37.
Crossref
Crossref
Nancy S. Green, Mark M. Lin & Mctthew D. Schorff. (2006) Immunoglobulin hypermutation in cultured cells. Immunological Reviews 162:1, pages 77-87.
Crossref
Crossref
Robert J. Colinas & Anne C. Walsh. (1998) Cell separation based on the reversible interaction between calmodulin and a calmodulin-binding peptide. Journal of Immunological Methods 212:1, pages 69-78.
Crossref
Crossref
Martha S Hayden, Lisa K Gilliland & Jeffrey A Ledbetter. (1997) Antibody engineering. Current Opinion in Immunology 9:2, pages 201-212.
Crossref
Crossref
Dianne M. Fishwild, Susan L. O'Donnell, Tasha Bengoechea, Debra V. Hudson, Fiona Harding, Susan L. Bernhard, Debbie Jones, Robert M. Kay, Kay M. Higgins, Stephen R. Schramm & Nils Lonberg. (1996) High-avidity human IgGκ monoclonal antibodies from a novel strain of minilocus transgenic mice. Nature Biotechnology 14:7, pages 845-851.
Crossref
Crossref